AC BioScience Ltd is a pre-clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.
Products, services, technology
ACB2112, a molecule in the Azole group, enhances the efficacy of checkpoint-inhibitor immune-therapy. Outstanding results found in reducing tumor burden in the CT26 model for CRC.
- http://www.ac-bioscience.com
- +41 79 308 99 29
- info@ac-bioscience.com
- Andreas Schläpfer